Plain-English translation of NCT07055841 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination of two treatments for advanced head and neck squamous cell carcinoma (a type of cancer in the head or neck region). You would receive , an immunotherapy drug that helps your immune system fight cancer, combined with chemotherapy drugs before surgery. The goal is to see if this combination can shrink the cancer and make surgery more effective.
Head and neck cancers that are diagnosed at an advanced stage are difficult to treat with surgery alone. Researchers believe that giving this medication and chemotherapy before surgery might help shrink the tumor, improve surgical outcomes, and give patients better chances of survival.
You likely qualify if…
You likely don't qualify if…
You would receive the immunotherapy medication combined with chemotherapy (docetaxel and cisplatin) as an initial treatment lasting 1 to 4 weeks. After completing this treatment phase, you would have surgery or radiation therapy. Following that, you would enter a follow-up phase where the research team monitors your health and response to treatment over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China